ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,07149
0,46%
Bitcoin
57.906,60
-4,44%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pacific Biosciences of California Inc (PACB)

  7. Pacific Biosciences of California Inc (PACB) News

PACB Pacific Biosciences of California Inc

1,72
0,07 (4,24%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:03:17
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Pacific Biosciences of California Inc PACB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,07 4,24% 1,72 01:03:17
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,66 1,58 1,83 1,69 1,65
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202414:05PRNUSPacBio Announces Preliminary First Quarter 2024 Revenue and..
27.3.202413:00PRNUSEstonia National Biobank Selects PacBio to Sequence 10,000..
22.3.202421:30PRNUSPacBio Grants Equity Incentive Award to New Employee
12.3.202414:05PRNUSPacBio Announces PureTarget™ Repeat Expansion Panel,..
06.3.202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:32EDGAR2Form 144 - Report of proposed sale of securities
05.3.202400:22EDGAR2Form 144 - Report of proposed sale of securities
26.2.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:05PRNUSPacBio to Present at Upcoming Investor Conferences
22.2.202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:17EDGAR2Form 144 - Report of proposed sale of securities
16.2.202423:54EDGAR2Form 144 - Report of proposed sale of securities
16.2.202423:52EDGAR2Form 144 - Report of proposed sale of securities
16.2.202423:06EDGAR2Form 144 - Report of proposed sale of securities
15.2.202422:07EDGAR2Form 8-K - Current report
15.2.202422:05PRNUSPacBio Announces Fourth Quarter and Fiscal Year 2023..
13.2.202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202413:00PRNUSExperiential Marketing Firm VOLO Events Agency Wins Best..
12.2.202423:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202412:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.2.202415:05PRNUSPacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96..
05.2.202412:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29.1.202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25.1.202422:03PRNUSPacBio to Report Fourth Quarter 2023 Financial Results on..
24.1.202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15.1.202415:05PRNUSPacBio Announces New Nanobind PanDNA Kit Enabling HiFi..
10.1.202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:26EDGAR2Form 144 - Report of proposed sale of securities
08.1.202414:03EDGAR2Form 8-K - Current report
08.1.202414:00PRNUSPacBio Announces Record Preliminary Fourth Quarter and Full..
27.12.202322:05PRNUSPacBio to Present at 42nd Annual J.P. Morgan Healthcare..
11.12.202314:06EDGAR2Form 8-K - Current report
11.12.202314:00PRNUSPacBio Announces the Retirement of David Botstein, Ph.D.,..
09.11.202322:10PRNUSPacBio to Present at Upcoming Investor Conferences
03.11.202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202314:05PRNUSPacBio Announces HiFi Solves, a Global Consortium of..
01.11.202314:05PRNUSPacBio Enables Rare and Inherited Disease Research by Adding..
31.10.202314:05PRNUSPacBio Announces Kinnex RNA Kits, Further Scaling HiFi..
30.10.202321:06EDGAR2Form 8-K - Current report
30.10.202321:03PRNUSPacBio Announces Third Quarter 2023 Financial Results
27.10.202323:00EDGAR2Form 8-K/A - Current report: [Amend]

Kürzlich von Ihnen besucht

NASDAQ
PACB
Pacific Biosciences of C...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten